BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22317852)

  • 61. Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results.
    Airò P; Danieli E; Parrinello G; Antonioli CM; Cavazzana I; Toniati P; Franceschini F; Cattaneo R
    Clin Exp Rheumatol; 2004; 22(5):573-8. PubMed ID: 15485010
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.
    Niermeijer JM; Eurelings M; van der Linden MW; Lokhorst HM; Franssen H; Fischer K; Teunissen LL; van den Berg LH; Schobben F; Wokke JH; Notermans NC
    Neurology; 2007 Jul; 69(1):50-9. PubMed ID: 17606880
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.
    Nannini C; West CP; Erwin PJ; Matteson EL
    Arthritis Res Ther; 2008; 10(5):R124. PubMed ID: 18937831
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma.
    Davas EM; Peppas C; Maragou M; Alvanou E; Hondros D; Dantis PC
    Clin Rheumatol; 1999; 18(6):455-61. PubMed ID: 10638770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Unusual association of systemic sclerosis and ankylosing spondylitis.
    Soledade CS; Sampaio-Barros PD; Samara AM; Marques-Neto JF
    Clin Rheumatol; 2005 Nov; 24(6):652-4. PubMed ID: 15338450
    [No Abstract]   [Full Text] [Related]  

  • 67. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
    Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
    J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis.
    Takahashi T; Asano Y; Taniguchi T; Yoshizaki A; Sato S
    J Dermatol; 2017 Apr; 44(4):468-469. PubMed ID: 28378437
    [No Abstract]   [Full Text] [Related]  

  • 74. Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases.
    Schulze AB; Evers G; Kümmel A; Rosenow F; Sackarnd J; Hering JP; Schülke C; Engelbertz JA; Görlich D; Barth PJ; Lenz G; Becker H; Mohr M; Schmidt LH
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(2):157-166. PubMed ID: 32476949
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
    Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
    Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Short-Term Intravenous Infusion of Cyclophosphamide in the Treatment of Refractory Pemphigus Vulgaris: A Retrospective Study.
    Zhang W; Wei S; Peng X; Xie S; Zhang Z; Zeng K; Lai K
    Dermatology; 2021; 237(2):185-190. PubMed ID: 32814321
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Efficacy of mycophenolate associated with methotrexate as a maintenance treatment for systemic sclerosis-associated interstitial lung disease].
    Gonzalez-Nieto JA; Martin-Suarez IJ; Gil-Muñoz FL
    Arch Bronconeumol; 2011 Nov; 47(11):575. PubMed ID: 21821334
    [No Abstract]   [Full Text] [Related]  

  • 78. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.
    Lorenzi AR; Johnson AH; Davies G; Gough A
    Ann Rheum Dis; 2001 Aug; 60(8):796-8. PubMed ID: 11454645
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.
    Strange C; Bolster MB; Roth MD; Silver RM; Theodore A; Goldin J; Clements P; Chung J; Elashoff RM; Suh R; Smith EA; Furst DE; Tashkin DP;
    Am J Respir Crit Care Med; 2008 Jan; 177(1):91-8. PubMed ID: 17901414
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intermittent intravenous cyclophosphamide pulse therapy for the treatment of active interstitial lung disease associated with collagen vascular diseases.
    Okada M; Suzuki K; Matsumoto M; Nakashima M; Nakanishi T; Takada K; Horikoshi H; Matsubara O; Ohsuzu F
    Mod Rheumatol; 2007; 17(2):131-6. PubMed ID: 17437168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.